speb/financial-data huggingface dataset:
Financial ratios for AGCO — annual report dated 2025-12-31
Total revenue: 10082000000
Gross profit: 2566800000
Operating income: 698700000
Net income: 726500000
Capital expenditures: 245900000
Operating cash flow: 988100000
Depreciation & amortization: 327600000
Net tangible assets: 1701700000
Owner earnings: 808200000
Return on net tangible assets (%): 47.49368278780043
Capex to operating income (%): 35.193931587233436
Buffett classification: The Good
Stock price: 103.84
P/E ratio: 10.349485813737097
Shares outstanding: 72408527
Book value: 4572700000
P/B ratio: 1.6443023692085639
Market cap (USD): 7518901443.68
Debt to equity: 0.5604784919194349
Current ratio: 1.3933925075755544
Quick ratio: 0.666863318226918
Effective tax rate (%): -12.857142857142856
Interest coverage ratio: 5.680487804878049
COGS to revenue (%): 74.54076572108708
R&D to revenue (%): 4.8373338623289035
SG&A to revenue (%): 12.986510612973618
Free cash flow (dilution-adjusted): 711800000
Buyback yield (%): 3.3249538097102875
Retained earnings: 6047200000
Inventory turnover: 2.7738530247665447
Receivables turnover: 9.340374282008524
Capitalized R&D asset: 999114000
ROCI (R&D-adjusted, %): 7.355733293439797
Rosenberg metric: -0.6740365111561866
FCF margin (%): 7.060107121602857
Revenue growth (%): -13.54753513578405
Rule of 40 score: -6.4874280141811935
Financial ratios for AGCO — quarterly report dated 2025-12-31
Total revenue: 2920200000
Gross profit: 741100000
Operating income: 276800000
Net income: 95500000
Capital expenditures: 88300000
Operating cash flow: 763600000
Depreciation & amortization: 86300000
Net tangible assets: 1701700000
Owner earnings: 93500000
Return on net tangible assets (%): 5.4945054945054945
Capex to operating income (%): 31.900289017341038
Buffett classification: The Good
Stock price: 103.84
P/E ratio: 10.349485813737097
Shares outstanding: 72408527
Book value: 4572700000
P/B ratio: 1.6443023692085639
Market cap (USD): 7518901443.68
Debt to equity: 0.5604784919194349
Current ratio: 1.3933925075755544
Quick ratio: 0.666863318226918
Effective tax rate (%): 47.834158415841586
Interest coverage ratio: 3.8876404494382024
COGS to revenue (%): 74.62160126018766
R&D to revenue (%): 4.482569687007739
SG&A to revenue (%): 10.831449900691734
Free cash flow (dilution-adjusted): 671600000
Buyback yield (%): 0
Retained earnings: 6047200000
Inventory turnover: 0.804303694681283
Receivables turnover: 2.7053918843802114
Capitalized R&D asset: 252184000
ROCI (R&D-adjusted, %): 3.3582285592844485
Rosenberg metric: 0.7691056910569106
FCF margin (%): 22.998424765427025
Revenue growth (%): 17.925937891208658
Rule of 40 score: 40.92436265663568
Financial ratios for AMBUJACEM.NS — annual report dated 2021-12-31
Capital expenditures: 0
Net tangible assets: 2318949348.381029
Buffett classification: The Gruesome
Stock price: 4.880424559989251
Shares outstanding: 2484817186
Book value: 4366353620.851807
P/B ratio: 2.777366167441106
Market cap (USD): 12126962821.63778
Debt to equity: 0.0146642472930514
Current ratio: 1.5160905819049995
Quick ratio: 1.2721715426005773
Buyback yield (%): 0
Retained earnings: 875480317.0764476
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMBUJACEM.NS — annual report dated 2022-12-31
Total revenue: 3740080878.8025107
Gross profit: 3292515692.9019794
Operating income: 312607436.0212458
Net income: 272945436.9869628
Capital expenditures: 543994447.1269917
Operating cash flow: -100941574.11878319
Depreciation & amortization: 156004345.72670206
Owner earnings: -115044664.41332686
Capex to operating income (%): 174.01839637941953
Buffett classification: The Gruesome
Stock price: 6.217407049734427
P/E ratio: 56.60149537607249
Shares outstanding: 2484817186
Market cap (USD): 15449119889.53766
Effective tax rate (%): 17.496898489381888
Interest coverage ratio: 16.656846980124783
COGS to revenue (%): 11.966724795636809
SG&A to revenue (%): 24.40503336848183
Free cash flow (dilution-adjusted): -651035731.5306615
Buyback yield (%): 0
Capitalized R&D asset: 0
FCF margin (%): -17.4069960684676
Rule of 40 score: -17.4069960684676
Financial ratios for AMBUJACEM.NS — annual report dated 2024-03-31
Total revenue: 3900922172.922413
Gross profit: 3000231442.619019
Operating income: 573282168.1256745
Net income: 567769516.7286246
Capital expenditures: 475013790.6223768
Operating cash flow: 677038014.1503778
Depreciation & amortization: 195215253.6275333
Net tangible assets: 3597828276.7717953
Owner earnings: 287970979.7337811
Return on net tangible assets (%): 8.00402235962655
Capex to operating income (%): 82.85863699117266
Buffett classification: The Gruesome
Stock price: 7.2610364683301345
P/E ratio: 31.777592267784815
Shares outstanding: 2484817186
Book value: 6096956469.600672
P/B ratio: 2.959238481468307
Market cap (USD): 18042348204.679462
Debt to equity: 0.013748531740755571
Current ratio: 1.9759639801861344
Quick ratio: 1.6784468145451188
Effective tax rate (%): 19.698953545564017
Interest coverage ratio: 17.29719950792387
COGS to revenue (%): 23.08917456891053
SG&A to revenue (%): 25.94424987065702
Free cash flow (dilution-adjusted): 139508334.3326538
Buyback yield (%): 0
Retained earnings: 1308829595.8748052
Inventory turnover: 2.081406659184437
Receivables turnover: 27.345379500500172
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.024290794868502
FCF margin (%): 3.576291147283767
Revenue growth (%): 4.300476362195671
Rule of 40 score: 7.876767509479438
Financial ratios for AMBUJACEM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 4015619923.554706
Buffett classification: The Gruesome
Stock price: 7.4909221213569035
Shares outstanding: 2484817186
Book value: 7156704491.161014
P/B ratio: 2.6008579855608347
Market cap (USD): 18613572026.135212
Debt to equity: 0.013005556285281725
Current ratio: 1.6955524116992526
Quick ratio: 1.3821273021380311
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMBUJACEM.NS — quarterly report dated 2024-12-31
Total revenue: 990569996.5030888
Gross profit: 780122391.8871663
Operating income: 128822706.6091619
Net income: 310405641.68317986
Capital expenditures: 0
Depreciation & amortization: 70716866.76768854
Owner earnings: 381122508.45086837
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.192096981000116
P/E ratio: 12.392033946560794
Shares outstanding: 2484817186
Market cap (USD): 15386228995.767803
Effective tax rate (%): -11.264451380271332
Interest coverage ratio: 16.497536945812808
COGS to revenue (%): 21.245101846295057
SG&A to revenue (%): 24.04949341617538
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMBUJACEM.NS — quarterly report dated 2025-03-31
Total revenue: 1156699789.57213
Gross profit: 943135375.2630348
Operating income: 137198971.24152443
Net income: 157991582.8851999
Capital expenditures: 0
Depreciation & amortization: 81114098.66729015
Net tangible assets: 4862992751.928922
Owner earnings: 239105681.55249006
Return on net tangible assets (%): 4.9168422358361115
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.22873147391761
P/E ratio: 24.490638568726315
Shares outstanding: 2484817186
Book value: 7475694411.971006
P/B ratio: 2.0703439922029836
Market cap (USD): 15477259013.369587
Debt to equity: 0.012330506360805474
Current ratio: 1.403793067085775
Quick ratio: 1.0969725378938349
Effective tax rate (%): 27.808937747721764
Interest coverage ratio: 82.12736179146256
COGS to revenue (%): 18.463253493639336
SG&A to revenue (%): 23.610503304391063
Buyback yield (%): 0
Retained earnings: 1713668459.200374
Inventory turnover: 0.43004371458635926
Receivables turnover: 6.221725460604917
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.744842115279114
Revenue growth (%): 16.77113113212723
Rule of 40 score: 16.77113113212723
Financial ratios for AMBUJACEM.NS — annual report dated 2025-03-31
Total revenue: 3934307926.1164365
Gross profit: 2954735796.1187744
Operating income: 430236146.8318915
Net income: 618901098.9010988
Capital expenditures: 1004382744.9146597
Operating cash flow: 261555997.19429505
Depreciation & amortization: 268534019.172317
Net tangible assets: 4862992751.928922
Owner earnings: -116947626.84124386
Return on net tangible assets (%): -2.4048488823031087
Capex to operating income (%): 233.4491772275721
Buffett classification: The Gruesome
Stock price: 6.22873147391761
P/E ratio: 25.007645067766916
Shares outstanding: 2484817186
Book value: 7475694411.971006
P/B ratio: 2.0703439922029836
Market cap (USD): 15477259013.369587
Debt to equity: 0.012330506360805474
Current ratio: 1.403793067085775
Quick ratio: 1.0969725378938349
Effective tax rate (%): 13.263987076627668
Interest coverage ratio: 17.042882282115404
COGS to revenue (%): 24.8982069627834
SG&A to revenue (%): 27.510877584791377
Free cash flow (dilution-adjusted): -753998129.5300443
Buyback yield (%): 0
Retained earnings: 1713668459.200374
Inventory turnover: 1.9725141889967301
Receivables turnover: 21.162088914041373
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.471572721825839
FCF margin (%): -19.164695384540412
Revenue growth (%): 0.8558425857804888
Rule of 40 score: -18.308852798759922
Financial ratios for AMBUJACEM.NS — quarterly report dated 2025-06-30
Total revenue: 1198702316.8733912
Gross profit: 1020319447.694828
Operating income: 128659021.76456822
Net income: 113463608.7058273
Capital expenditures: 0
Depreciation & amortization: 100815586.23917623
Owner earnings: 214279194.9450035
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.723730400187223
P/E ratio: 28.713465311631367
Shares outstanding: 2484817186
Market cap (USD): 16707240852.415869
Effective tax rate (%): 27.237117579523197
Interest coverage ratio: 16.376526660708965
COGS to revenue (%): 14.881331809205486
SG&A to revenue (%): 23.648027988766227
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 3.6312384319528728
Rule of 40 score: 3.6312384319528728
Financial ratios for AMBUJACEM.NS — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.3939120631341595
P/E ratio: 27.30498715791935
Shares outstanding: 2484817186
Market cap (USD): 15887702580.248476
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMBUJACEM.NS — quarterly report dated 2025-12-31
Total revenue: 1134067060.265122
Gross profit: 921871449.2592181
Operating income: 43894396.791801274
Net income: 40878912.777097024
Capital expenditures: 0
Depreciation & amortization: 106831903.7540381
Owner earnings: 147710816.5311351
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.166982288069511
P/E ratio: 49.06228093840085
Shares outstanding: 2484817186
Market cap (USD): 15323823575.152725
Effective tax rate (%): 11.018161538275018
Interest coverage ratio: 6.695666949872558
COGS to revenue (%): 18.7110285132783
SG&A to revenue (%): 23.20804831187405
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ANTX — annual report dated 2022-12-31
Total revenue: 0
Operating income: -42262000
Net income: -40956000
Capital expenditures: 0
Operating cash flow: -33462000
Net tangible assets: 95372000
Owner earnings: -40956000
Return on net tangible assets (%): -42.94342154930168
Buffett classification: The Gruesome
Stock price: 9.53
Shares outstanding: 36016161
Book value: 95372000
P/B ratio: 3.5988971011407958
Market cap (USD): 343234014.33
Debt to equity: 0.0005557186595646521
Current ratio: 13.724046757584192
Quick ratio: 13.724046757584192
Free cash flow (dilution-adjusted): -37853000
Buyback yield (%): 0
Retained earnings: -89723000
Capitalized R&D asset: 29511000
ROCI (R&D-adjusted, %): -18.08704007687072
Rule of 40 score: 0
Financial ratios for ANTX — annual report dated 2023-12-31
Total revenue: 0
Operating income: -69635000
Net income: -64732000
Capital expenditures: 0
Operating cash flow: -53288000
Net tangible assets: 124701000
Owner earnings: -64732000
Return on net tangible assets (%): -51.909768165451766
Buffett classification: The Gruesome
Stock price: 20.49
Shares outstanding: 36016161
Book value: 124701000
P/B ratio: 5.917924787211009
Market cap (USD): 737971138.89
Debt to equity: 0
Current ratio: 7.869187495549384
Quick ratio: 7.869187495549384
Free cash flow (dilution-adjusted): -61700000
Buyback yield (%): 0
Retained earnings: -154455000
Capitalized R&D asset: 74643370
ROCI (R&D-adjusted, %): -21.51619999768909
Rule of 40 score: 0
Financial ratios for ANTX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.07
Shares outstanding: 36016161
Market cap (USD): 38537292.27
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ANTX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.38
Shares outstanding: 36016161
Market cap (USD): 49702302.18
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ANTX — annual report dated 2024-12-31
Total revenue: 0
Operating income: -54554000
Net income: -51321000
Capital expenditures: 0
Operating cash flow: -49257000
Net tangible assets: 81849000
Owner earnings: -51321000
Return on net tangible assets (%): -62.70204889491625
Buffett classification: The Gruesome
Stock price: 1.38
Shares outstanding: 36016161
Book value: 81849000
P/B ratio: 0.6072438536817798
Market cap (USD): 49702302.18
Debt to equity: 0
Current ratio: 8.425669075991404
Quick ratio: 8.425669075991404
Free cash flow (dilution-adjusted): -57595000
Buyback yield (%): 0
Retained earnings: -205776000
Capitalized R&D asset: 86990200
ROCI (R&D-adjusted, %): -32.98365150589042
Rule of 40 score: 0
Financial ratios for ANTX — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -11537000
Net income: -10649000
Capital expenditures: 0
Operating cash flow: -10624000
Net tangible assets: 73329000
Owner earnings: -10649000
Return on net tangible assets (%): -14.522221767649906
Buffett classification: The Gruesome
Stock price: 1.36
Shares outstanding: 36016161
Book value: 73329000
P/B ratio: 0.6679755480096552
Market cap (USD): 48981978.96
Debt to equity: 0
Current ratio: 8.679685550286997
Quick ratio: 8.679685550286997
Free cash flow (dilution-adjusted): -12671000
Buyback yield (%): 0
Retained earnings: -216425000
Capitalized R&D asset: 7690000
ROCI (R&D-adjusted, %): -7.912135836449886
Rule of 40 score: 0
Financial ratios for ANTX — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -7216000
Net income: -6462000
Capital expenditures: 0
Operating cash flow: -7599000
Net tangible assets: 68842000
Owner earnings: -6462000
Return on net tangible assets (%): -9.386711600476454
Buffett classification: The Gruesome
Stock price: 1.06
Shares outstanding: 36016161
Book value: 68842000
P/B ratio: 0.5545616144214288
Market cap (USD): 38177130.660000004
Debt to equity: 0
Current ratio: 9.669769440068738
Quick ratio: 9.669769440068738
Free cash flow (dilution-adjusted): -9597000
Buyback yield (%): 0
Retained earnings: -222887000
Capitalized R&D asset: 8352300
ROCI (R&D-adjusted, %): -9.904876396314236
Rule of 40 score: 0
Financial ratios for ANTX — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -10040000
Net income: -9353000
Capital expenditures: 0
Operating cash flow: -6375000
Net tangible assets: 60377000
Owner earnings: -9353000
Return on net tangible assets (%): -15.490998227801978
Buffett classification: The Gruesome
Stock price: 1.27
Shares outstanding: 36016161
Book value: 60377000
P/B ratio: 0.7575819346771122
Market cap (USD): 45740524.47
Debt to equity: 0
Current ratio: 9.334499854184893
Quick ratio: 9.334499854184893
Free cash flow (dilution-adjusted): -7176000
Buyback yield (%): 0
Retained earnings: -232240000
Capitalized R&D asset: 11681700
ROCI (R&D-adjusted, %): -12.494443187752946
Rule of 40 score: 0
Financial ratios for ANTX — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -9316000
Net income: -8710000
Capital expenditures: 0
Operating cash flow: -5236000
Net tangible assets: 53060000
Owner earnings: -8710000
Return on net tangible assets (%): -16.415378816434227
Buffett classification: The Gruesome
Stock price: 1.14
Shares outstanding: 36016161
Book value: 53060000
P/B ratio: 0.7738112238974745
Market cap (USD): 41058423.54
Debt to equity: 0
Current ratio: 6.873509174311927
Quick ratio: 6.873509174311927
Free cash flow (dilution-adjusted): -6636000
Buyback yield (%): 0
Retained earnings: -240950000
Capitalized R&D asset: 12625000
ROCI (R&D-adjusted, %): -12.34530407713917
Rule of 40 score: 0
Financial ratios for ANTX — annual report dated 2025-12-31
Total revenue: 0
Operating income: -38109000
Net income: -35174000
Capital expenditures: 0
Operating cash flow: -29834000
Net tangible assets: 53060000
Owner earnings: -35174000
Return on net tangible assets (%): -66.29099133056917
Buffett classification: The Gruesome
Stock price: 1.14
Shares outstanding: 36016161
Book value: 53060000
P/B ratio: 0.7738112238974745
Market cap (USD): 41058423.54
Debt to equity: 0
Current ratio: 6.873509174311927
Quick ratio: 6.873509174311927
Free cash flow (dilution-adjusted): -36080000
Buyback yield (%): 0
Retained earnings: -240950000
Capitalized R&D asset: 70003390
ROCI (R&D-adjusted, %): -43.318346323724974
Rule of 40 score: 0
Financial ratios for BCJ.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 49.31868131868132
Shares outstanding: 2993098
Market cap (USD): 147615646.41758242
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCJ.SW — annual report dated 2022-12-31
Total revenue: 57529347.82608695
Net income: 11108695.652173912
Capital expenditures: 1213043.4782608696
Operating cash flow: 82757608.69565217
Net tangible assets: 308669565.2173913
Owner earnings: 9895652.173913043
Return on net tangible assets (%): 3.205904724342902
Buffett classification: The Gruesome
Stock price: 52.17391304347826
P/E ratio: 14.05760313111546
Shares outstanding: 2993098
Book value: 308669565.217391
P/B ratio: 0.5059184719835483
Market cap (USD): 156161634.7826087
Debt to equity: 3.7695791193622035
Effective tax rate (%): 27.059243397573162
COGS to revenue (%): 0
SG&A to revenue (%): 3.0230317229391424
Free cash flow (dilution-adjusted): 79155434.78260869
Buyback yield (%): 0
Retained earnings: 11318478.260869564
Receivables turnover: 17.53711066931743
Capitalized R&D asset: 0
FCF margin (%): 137.59139947474824
Rule of 40 score: 137.59139947474824
Financial ratios for BCJ.SW — annual report dated 2023-12-31
Total revenue: 82770238.0952381
Net income: 15758333.333333334
Capital expenditures: 3515476.1904761908
Operating cash flow: -54615476.190476194
Net tangible assets: 362438095.2380952
Owner earnings: 12242857.142857144
Return on net tangible assets (%): 3.377916754256885
Buffett classification: The Gruesome
Stock price: 58.5
P/E ratio: 11.111342125859332
Shares outstanding: 2993098
Book value: 362438095.2380953
P/B ratio: 0.4831065919960058
Market cap (USD): 175096233
Debt to equity: 3.7190062013874288
Effective tax rate (%): 29.649710306702815
COGS to revenue (%): 0
SG&A to revenue (%): 2.8909632229205915
Free cash flow (dilution-adjusted): -58130952.38095238
Buyback yield (%): 0.05575165493083316
Retained earnings: 15952380.952380953
Receivables turnover: 17.120659935976363
Capitalized R&D asset: 0
FCF margin (%): -70.23170854488183
Revenue growth (%): 43.87480689935016
Rule of 40 score: -26.356901645531664
Financial ratios for BCJ.SW — annual report dated 2024-12-31
Total revenue: 81226666.66666667
Net income: 14978888.888888888
Capital expenditures: 5240000
Operating cash flow: 88165555.55555555
Net tangible assets: 359647777.7777778
Owner earnings: 9738888.888888888
Return on net tangible assets (%): 2.707896305953664
Buffett classification: The Gruesome
Stock price: 58.67777777777778
P/E ratio: 11.725057887397078
Shares outstanding: 2993098
Book value: 359647777.7777786
P/B ratio: 0.48833428193633777
Market cap (USD): 175628339.31111112
Debt to equity: 3.804098454351934
Effective tax rate (%): 29.84492089925062
COGS to revenue (%): 0
SG&A to revenue (%): 2.7084701247537755
Free cash flow (dilution-adjusted): 81983333.33333333
Buyback yield (%): 0.05630577005782386
Retained earnings: 15145555.555555556
Capitalized R&D asset: 0
FCF margin (%): 100.93154957321076
Revenue growth (%): -1.8648870223078853
Rule of 40 score: 99.06666255090288
Financial ratios for BCJ.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 359647777.7777778
Buffett classification: The Gruesome
Stock price: 58.67777777777778
Shares outstanding: 2993098
Book value: 359647777.7777786
P/B ratio: 0.48833428193633777
Market cap (USD): 175628339.31111112
Debt to equity: 3.804098454351934
Buyback yield (%): 0
Retained earnings: 15145555.555555556
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCJ.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 413630000
Buffett classification: The Gruesome
Stock price: 70.9875
Shares outstanding: 2993098
Book value: 413630000
P/B ratio: 0.5136777899934724
Market cap (USD): 212472544.275
Debt to equity: 3.5120095254212704
Buyback yield (%): 0
Retained earnings: 11661250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCML — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.95
Shares outstanding: 10909317
Market cap (USD): 184912923.15
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCML — annual report dated 2022-12-31
Total revenue: 100895000
Net income: 23730000
Capital expenditures: 843000
Operating cash flow: 39612000
Depreciation & amortization: 4019000
Net tangible assets: 273110000
Owner earnings: 26906000
Return on net tangible assets (%): 9.851708102962178
Buffett classification: The Gruesome
Stock price: 17.32
P/E ratio: 7.962468202275601
Shares outstanding: 10909317
Book value: 317149000
P/B ratio: 0.5957747634077358
Market cap (USD): 188949370.44
Debt to equity: 0.28167517476012854
Effective tax rate (%): 26.84505826499784
COGS to revenue (%): 0
SG&A to revenue (%): 42.372763764309425
Free cash flow (dilution-adjusted): 37747000
Buyback yield (%): 9.504662523182525
Retained earnings: 124122000
Receivables turnover: 3.3141177243463407
Capitalized R&D asset: 0
FCF margin (%): 37.412161157639126
Rule of 40 score: 37.412161157639126
Financial ratios for BCML — annual report dated 2023-12-31
Total revenue: 104449000
Net income: 27425000
Capital expenditures: 2123000
Operating cash flow: 30802000
Depreciation & amortization: 2963000
Net tangible assets: 270116000
Owner earnings: 28265000
Return on net tangible assets (%): 10.464022864250914
Buffett classification: The Gruesome
Stock price: 21.98
P/E ratio: 8.74336509243391
Shares outstanding: 10909317
Book value: 312869000
P/B ratio: 0.7664127403481968
Market cap (USD): 239786787.66
Debt to equity: 0.2787045057196462
Effective tax rate (%): 28.127784475077313
COGS to revenue (%): 0
SG&A to revenue (%): 41.7332861013509
Free cash flow (dilution-adjusted): 27953000
Buyback yield (%): 10.056433982589514
Retained earnings: 146261000
Receivables turnover: 3.2715968176407944
Capitalized R&D asset: 0
FCF margin (%): 26.7623433445988
Revenue growth (%): 3.5224738589622877
Rule of 40 score: 30.28481720356109
Financial ratios for BCML — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 22.42
Shares outstanding: 10909317
Market cap (USD): 244586887.14000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCML — annual report dated 2024-12-31
Total revenue: 97136000
Net income: 23614000
Capital expenditures: 1701000
Operating cash flow: 30357000
Depreciation & amortization: 3267000
Net tangible assets: 282835000
Owner earnings: 25180000
Return on net tangible assets (%): 8.902717131896688
Buffett classification: The Gruesome
Stock price: 25.5
P/E ratio: 11.780620966375878
Shares outstanding: 10909317
Book value: 324366000
P/B ratio: 0.8576348430476683
Market cap (USD): 278187583.5
Debt to equity: 0.2674879611303281
Effective tax rate (%): 26.48194271481943
COGS to revenue (%): 0
SG&A to revenue (%): 42.67212979739746
Free cash flow (dilution-adjusted): 28068000
Buyback yield (%): 3.3240160770870637
Retained earnings: 164831000
Receivables turnover: 3.3989782350059485
Capitalized R&D asset: 0
FCF margin (%): 28.89556909899522
Revenue growth (%): -7.001503125927486
Rule of 40 score: 21.894065973067736
Financial ratios for BCML — quarterly report dated 2024-12-31
Capital expenditures: 58000
Buffett classification: The Gruesome
Stock price: 25.5
Shares outstanding: 10909317
Market cap (USD): 278187583.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BCML — quarterly report dated 2025-03-31
Total revenue: 24332000
Net income: 5702000
Capital expenditures: 143000
Operating cash flow: 9280000
Depreciation & amortization: 733000
Net tangible assets: 288069000
Owner earnings: 6292000
Return on net tangible assets (%): 2.184198924563212
Buffett classification: The Gruesome
Stock price: 24.06
P/E ratio: 11.508162356190809
Shares outstanding: 10909317
Book value: 329337000
P/B ratio: 0.7969896094881534
Market cap (USD): 262478167.01999998
Debt to equity: 0.26556384493694907
Effective tax rate (%): 25.84211210820653
COGS to revenue (%): 0
SG&A to revenue (%): 43.28867335196449
Free cash flow (dilution-adjusted): 8986000
Buyback yield (%): 0.4975651936416057
Retained earnings: 168862000
Receivables turnover: 0.9396408573083607
Capitalized R&D asset: 0
FCF margin (%): 36.93079072825908
Rule of 40 score: 36.93079072825908
Financial ratios for BCML — quarterly report dated 2025-06-30
Total revenue: 24814000
Net income: 6364000
Capital expenditures: 749000
Operating cash flow: 6368000
Depreciation & amortization: 739000
Net tangible assets: 289537000
Owner earnings: 6354000
Return on net tangible assets (%): 2.1945381764679475
Buffett classification: The Gruesome
Stock price: 26.68
P/E ratio: 24.12237506713078
Shares outstanding: 10909317
Book value: 330562000
P/B ratio: 0.8805022282052988
Market cap (USD): 291060577.56
Debt to equity: 0.262059764885256
Effective tax rate (%): 26.984855438274437
COGS to revenue (%): 0
SG&A to revenue (%): 41.93197388570968
Free cash flow (dilution-adjusted): 5468000
Buyback yield (%): 1.3333994017791573
Retained earnings: 173028000
Receivables turnover: 0.9853472580709208
Capitalized R&D asset: 0
FCF margin (%): 22.035947449020714
Revenue growth (%): 1.98093046194312
Rule of 40 score: 24.016877910963835
Financial ratios for BCML — quarterly report dated 2025-09-30
Total revenue: 26002000
Net income: 5007000
Capital expenditures: 1116000
Operating cash flow: 7345000
Depreciation & amortization: 1736000
Net tangible assets: 293486000
Owner earnings: 5627000
Return on net tangible assets (%): 1.9172975883006345
Buffett classification: The Gruesome
Stock price: 27.91
P/E ratio: 17.83395053417677
Shares outstanding: 10909317
Book value: 334269000
P/B ratio: 0.9108802714879334
Market cap (USD): 304479037.47
Debt to equity: 0.06940517966069244
Effective tax rate (%): 25.690115761353518
COGS to revenue (%): 0
SG&A to revenue (%): 41.542958233982006
Free cash flow (dilution-adjusted): 6056000
Buyback yield (%): 0.2985427199038498
Retained earnings: 175311000
Receivables turnover: 1.0518608414239483
Capitalized R&D asset: 0
FCF margin (%): 23.290516114145067
Revenue growth (%): 4.787619891996454
Rule of 40 score: 28.07813600614152
Financial ratios for BCML — annual report dated 2025-12-31
Total revenue: 101363000
Net income: 23931000
Capital expenditures: 1746000
Operating cash flow: 31831000
Depreciation & amortization: 2991000
Net tangible assets: 297971000
Owner earnings: 25176000
Return on net tangible assets (%): 8.449144379822197
Buffett classification: The Gruesome
Stock price: 28.82
P/E ratio: 13.138043372195062
Shares outstanding: 10909317
Book value: 338554000
P/B ratio: 0.928674645521837
Market cap (USD): 314406515.94
Debt to equity: 0.06611943737188158
Effective tax rate (%): 26.630284820798973
COGS to revenue (%): 0
SG&A to revenue (%): 42.18995096830204
Free cash flow (dilution-adjusted): 29432000
Buyback yield (%): 2.1974735413303215
Retained earnings: 178903000
Receivables turnover: 4.3311968551040465
Capitalized R&D asset: 0
FCF margin (%): 29.036236101930683
Revenue growth (%): 4.351630703343766
Rule of 40 score: 33.38786680527445
Financial ratios for BCML — quarterly report dated 2025-12-31
Total revenue: 26218000
Net income: 6858000
Capital expenditures: 262000
Operating cash flow: 8838000
Depreciation & amortization: 199000
Net tangible assets: 297971000
Owner earnings: 6795000
Return on net tangible assets (%): 2.2804232626665013
Buffett classification: The Gruesome
Stock price: 28.82
P/E ratio: 13.138043372195062
Shares outstanding: 10909317
Book value: 338554000
P/B ratio: 0.928674645521837
Market cap (USD): 314406515.94
Debt to equity: 0.06611943737188158
Effective tax rate (%): 27.612412919569344
COGS to revenue (%): 0
SG&A to revenue (%): 42.06270501182394
Free cash flow (dilution-adjusted): 8922000
Buyback yield (%): 0.2585824271387395
Retained earnings: 178903000
Receivables turnover: 1.1202837243088493
Capitalized R&D asset: 0
FCF margin (%): 34.03005568693264
Revenue growth (%): 0.8307053303592031
Rule of 40 score: 34.86076101729184
Financial ratios for BMY — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 51.22
Shares outstanding: 2042071247
Market cap (USD): 104594889271.34
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMY — annual report dated 2022-12-31
Total revenue: 46159000000
Gross profit: 36022000000
Operating income: 9104000000
Net income: 6345000000
Capital expenditures: 1118000000
Operating cash flow: 13066000000
Depreciation & amortization: 10276000000
Net tangible assets: -26443000000
Owner earnings: 15503000000
Return on net tangible assets (%): -58.6279922852929
Capex to operating income (%): 12.280316344463973
Buffett classification: The Great
Stock price: 60.94
P/E ratio: 19.612895475520883
Shares outstanding: 2042071247
Book value: 31118000000
P/B ratio: 3.9990944724011825
Market cap (USD): 124443821792.18
Debt to equity: 1.3084709814255415
Current ratio: 1.2459113750571038
Quick ratio: 1.13905893101873
Effective tax rate (%): 17.736289381563594
Interest coverage ratio: 7.3896103896103895
COGS to revenue (%): 21.96104768300873
R&D to revenue (%): 20.60053294048831
SG&A to revenue (%): 16.928442990532723
Free cash flow (dilution-adjusted): 11491000000
Buyback yield (%): 6.429407169253926
Retained earnings: 25503000000
Inventory turnover: 4.333903377511757
Receivables turnover: 3.3119753175001794
Capitalized R&D asset: 9509000000
ROCI (R&D-adjusted, %): 18.289337075679878
FCF margin (%): 24.89438679347473
Rule of 40 score: 24.89438679347473
Financial ratios for BMY — annual report dated 2023-12-31
Total revenue: 45006000000
Gross profit: 34313000000
Operating income: 8195000000
Net income: 8040000000
Capital expenditures: 1209000000
Operating cash flow: 13860000000
Depreciation & amortization: 9760000000
Net tangible assets: -19224000000
Owner earnings: 16591000000
Return on net tangible assets (%): -86.30357885975863
Capex to operating income (%): 14.752898108602807
Buffett classification: The Great
Stock price: 45.01
P/E ratio: 11.432043137745024
Shares outstanding: 2042071247
Book value: 29485000000
P/B ratio: 3.117301232066135
Market cap (USD): 91913626827.47
Debt to equity: 1.4062743768017636
Current ratio: 1.4270954990566884
Quick ratio: 1.3075195400233581
Effective tax rate (%): 4.739336492890995
Interest coverage ratio: 7.028301886792453
COGS to revenue (%): 23.759054348309114
R&D to revenue (%): 20.66168955250411
SG&A to revenue (%): 17.26880860329734
Free cash flow (dilution-adjusted): 12133000000
Buyback yield (%): 5.608526371912611
Retained earnings: 28766000000
Inventory turnover: 4.016904583020286
Receivables turnover: 2.948506289308176
Capitalized R&D asset: 15670030000
ROCI (R&D-adjusted, %): 12.673640142010708
Rosenberg metric: -0.17972447155326532
FCF margin (%): 26.958627738523756
Revenue growth (%): -2.4978877358694946
Rule of 40 score: 24.460740002654262
Financial ratios for BMY — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 47.15
Shares outstanding: 2042071247
Market cap (USD): 96283659296.05
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMY — annual report dated 2024-12-31
Total revenue: 48300000000
Gross profit: 34332000000
Operating income: 5887000000
Net income: -8933000000
Capital expenditures: 1248000000
Operating cash flow: 15190000000
Depreciation & amortization: 9600000000
Net tangible assets: -29027000000
Owner earnings: -581000000
Capex to operating income (%): 21.19925259045354
Buffett classification: The Great
Stock price: 52.12
Shares outstanding: 2042071247
Book value: 16388000000
P/B ratio: 6.494554148989504
Market cap (USD): 106432753393.64
Debt to equity: 3.1242372467659263
Current ratio: 1.2526289223521494
Quick ratio: 1.145074451081013
Interest coverage ratio: 3.0236260914227016
COGS to revenue (%): 28.91925465838509
R&D to revenue (%): 23.10351966873706
SG&A to revenue (%): 17.42028985507246
Free cash flow (dilution-adjusted): 13435000000
Buyback yield (%): 0
Retained earnings: 14912000000
Inventory turnover: 5.462651544779038
Receivables turnover: 3.348585690515807
Capitalized R&D asset: 20527300000
ROCI (R&D-adjusted, %): 7.897596476129831
Rosenberg metric: 0.0020432304548876224
FCF margin (%): 27.815734989648032
Revenue growth (%): 7.319024130115985
Rule of 40 score: 35.13475911976402
Financial ratios for BMY — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 52.12
Shares outstanding: 2042071247
Market cap (USD): 106432753393.64
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BMY — quarterly report dated 2025-03-31
Total revenue: 11201000000
Gross profit: 8168000000
Operating income: 3497000000
Net income: 2462000000
Capital expenditures: 260000000
Operating cash flow: 1954000000
Depreciation & amortization: 1012000000
Net tangible assets: -27150000000
Owner earnings: 3214000000
Return on net tangible assets (%): -11.837937384898712
Capex to operating income (%): 7.434944237918216
Buffett classification: The Great
Stock price: 56.82
P/E ratio: 11.782137312605606
Shares outstanding: 2042071247
Book value: 17448000000
P/B ratio: 6.650073833937413
Market cap (USD): 116030488254.54
Debt to equity: 2.936668959193031
Current ratio: 1.2788948899044454
Quick ratio: 1.1681346073950976
Effective tax rate (%): 17.13227869404241
Interest coverage ratio: 7.078947368421052
COGS to revenue (%): 27.077939469690204
R&D to revenue (%): 20.14998660833854
SG&A to revenue (%): 14.141594500491028
Free cash flow (dilution-adjusted): 1550000000
Buyback yield (%): 0
Retained earnings: 16106000000
Inventory turnover: 1.1376594148537134
Receivables turnover: 0.7679281502810914
Capitalized R&D asset: 2257000000
ROCI (R&D-adjusted, %): 7.083109109619434
FCF margin (%): 13.838050174091599
Rule of 40 score: 13.838050174091599
Financial ratios for BMY — quarterly report dated 2025-06-30
Total revenue: 12269000000
Gross profit: 8897000000
Operating income: 3774000000
Net income: 1313000000
Capital expenditures: 361000000
Operating cash flow: 3917000000
Depreciation & amortization: 1011000000
Net tangible assets: -26004000000
Owner earnings: 1963000000
Return on net tangible assets (%): -7.548838640209199
Capex to operating income (%): 9.565447800741918
Buffett classification: The Great
Stock price: 43.59
P/E ratio: 23.579837260060927
Shares outstanding: 2042071247
Book value: 17489000000
P/B ratio: 5.0897069962107615
Market cap (USD): 89013885656.73001
Debt to equity: 2.9120590085196407
Current ratio: 1.2068439407149085
Quick ratio: 1.1074179017727406
Effective tax rate (%): 25.944726452340667
Interest coverage ratio: 7.781443298969072
COGS to revenue (%): 27.48390251854267
R&D to revenue (%): 21.028608688564677
SG&A to revenue (%): 13.96201809438422
Free cash flow (dilution-adjusted): 3419000000
Buyback yield (%): 0
Retained earnings: 16154000000
Inventory turnover: 1.2320058458165875
Receivables turnover: 0.8124627508112046
Capitalized R&D asset: 4092190000
ROCI (R&D-adjusted, %): 6.655887170804382
Rosenberg metric: 0.3229951262738148
FCF margin (%): 27.866981824109544
Revenue growth (%): 9.534862958664405
Rule of 40 score: 37.40184478277395
Financial ratios for BMY — quarterly report dated 2025-09-30
Total revenue: 12222000000
Gross profit: 8787000000
Operating income: 3639000000
Net income: 2201000000
Capital expenditures: 320000000
Operating cash flow: 6311000000
Depreciation & amortization: 1011000000
Net tangible assets: -23918000000
Owner earnings: 2892000000
Return on net tangible assets (%): -12.091311982607241
Capex to operating income (%): 8.793624622148942
Buffett classification: The Great
Stock price: 43.03
P/E ratio: 14.703869772156962
Shares outstanding: 2042071247
Book value: 18600000000
P/B ratio: 4.724211062280108
Market cap (USD): 87870325758.41
Debt to equity: 2.7441397849462366
Current ratio: 1.2663491612169462
Quick ratio: 1.1683252772249075
Effective tax rate (%): 29.511881824020552
Interest coverage ratio: 7.58125
COGS to revenue (%): 28.10505645557192
R&D to revenue (%): 20.684012436589754
SG&A to revenue (%): 14.63753886434299
Free cash flow (dilution-adjusted): 5852000000
Buyback yield (%): 0
Retained earnings: 17093000000
Inventory turnover: 1.2454677302393038
Receivables turnover: 0.8362068965517241
Capitalized R&D asset: 5001410000
ROCI (R&D-adjusted, %): 5.032919387464424
Rosenberg metric: -0.04263565891472868
FCF margin (%): 47.88087056128293
Revenue growth (%): -0.38307930556687586
Rule of 40 score: 47.49779125571606
Financial ratios for BMY — quarterly report dated 2025-12-31
Total revenue: 12503000000
Gross profit: 8406000000
Operating income: 2813000000
Net income: 1087000000
Capital expenditures: 370000000
Operating cash flow: 1974000000
Depreciation & amortization: 977000000
Net tangible assets: -22634000000
Owner earnings: 1694000000
Return on net tangible assets (%): -7.484315631351064
Capex to operating income (%): 13.153217205830076
Buffett classification: The Great
Stock price: 52.18
P/E ratio: 15.086404880144414
Shares outstanding: 2042071247
Book value: 18506000000
P/B ratio: 5.757877319164595
Market cap (USD): 106555277668.46
Debt to equity: 2.547227926078029
Current ratio: 1.2550711021907162
Quick ratio: 1.1401972925652304
Effective tax rate (%): 26.122448979591837
Interest coverage ratio: 6.511574074074074
COGS to revenue (%): 32.768135647444616
R&D to revenue (%): 20.68303607134288
SG&A to revenue (%): 17.443813484763655
Free cash flow (dilution-adjusted): 1471000000
Buyback yield (%): 0
Retained earnings: 16896000000
Inventory turnover: 1.5230483271375466
Receivables turnover: 0.8607917383820999
Capitalized R&D asset: 5131160000
ROCI (R&D-adjusted, %): 3.9501714419932914
Rosenberg metric: -0.1507120253164557
FCF margin (%): 11.765176357674157
Revenue growth (%): 2.299132711503846
Rule of 40 score: 14.064309069178003
Financial ratios for BMY — annual report dated 2025-12-31
Total revenue: 48195000000
Gross profit: 34259000000
Operating income: 13724000000
Net income: 7055000000
Capital expenditures: 1311000000
Operating cash flow: 14156000000
Depreciation & amortization: 4011000000
Net tangible assets: -22634000000
Owner earnings: 9755000000
Return on net tangible assets (%): -43.0988777944685
Capex to operating income (%): 9.552608568930342
Buffett classification: The Great
Stock price: 52.18
P/E ratio: 15.10351207207087
Shares outstanding: 2042071247
Book value: 18506000000
P/B ratio: 5.757877319164595
Market cap (USD): 106555277668.46
Debt to equity: 2.547227926078029
Current ratio: 1.2550711021907162
Quick ratio: 1.1401972925652304
Effective tax rate (%): 24.356775300171527
Interest coverage ratio: 7.25753569539926
COGS to revenue (%): 28.915862641352835
R&D to revenue (%): 20.647370059134765
SG&A to revenue (%): 15.078327627347235
Free cash flow (dilution-adjusted): 12292000000
Buyback yield (%): 0
Retained earnings: 16896000000
Inventory turnover: 5.180669144981413
Receivables turnover: 3.3180722891566266
Capitalized R&D asset: 20496200000
ROCI (R&D-adjusted, %): 15.540750467951984
Rosenberg metric: -0.0065418048212205395
FCF margin (%): 25.50472040668119
Revenue growth (%): -0.21739130434782608
Rule of 40 score: 25.287329102333366
Financial ratios for CCU — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.18
Shares outstanding: 184751436
Market cap (USD): 2619775362.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCU — annual report dated 2022-12-31
Total revenue: 3167564191.588785
Gross profit: 1397791634.3457944
Operating income: 265825473.13084114
Net income: 158276228.97196263
Capital expenditures: 216223188.08411214
Net tangible assets: 1174844579.4392524
Owner earnings: -57946959.11214951
Return on net tangible assets (%): -4.932308504994533
Capex to operating income (%): 81.34028147772189
Buffett classification: The Gruesome
Stock price: 12.05
P/E ratio: 14.0656295532184
Shares outstanding: 184751436
Book value: 1677533940.4205608
P/B ratio: 1.3270997087795875
Market cap (USD): 2226254803.8
Debt to equity: 0.9558411200662553
Current ratio: 2.084856534713901
Quick ratio: 1.4601763612534728
Effective tax rate (%): 0.19443544802131915
Interest coverage ratio: 2.996759947781453
COGS to revenue (%): 55.87171877818549
SG&A to revenue (%): 25.507012237565952
Free cash flow (dilution-adjusted): -184189646.02803737
Buyback yield (%): 0
Retained earnings: 984865877.3364486
Inventory turnover: 3.04223059818271
Receivables turnover: 5.430175578200453
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.132686837975008
FCF margin (%): -5.8148670362273425
Rule of 40 score: -5.8148670362273425
Financial ratios for CCU — annual report dated 2023-12-31
Total revenue: 2900113116.0698137
Gross profit: 1341725561.810454
Operating income: 282589552.8124435
Net income: 133868514.8761078
Capital expenditures: 139230734.53608248
Net tangible assets: 1059922136.6883705
Owner earnings: -5362219.659974679
Return on net tangible assets (%): -0.5059069411200754
Capex to operating income (%): 49.26959724816536
Buffett classification: The Good
Stock price: 11.75
P/E ratio: 16.216130992482082
Shares outstanding: 184751436
Book value: 1511781720.2477846
P/B ratio: 1.4359410118043998
Market cap (USD): 2170829373
Debt to equity: 0.9939283679065652
Current ratio: 2.329779703206292
Quick ratio: 1.6879491824370938
Effective tax rate (%): -14.799847977166872
Interest coverage ratio: 3.245652158559085
COGS to revenue (%): 53.73540589241779
SG&A to revenue (%): 26.012971986240363
Free cash flow (dilution-adjusted): 186120418.475312
Buyback yield (%): 0
Retained earnings: 1012696183.758365
Inventory turnover: 3.124351923284242
Receivables turnover: 5.2878067041724
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.135514091898154
FCF margin (%): 6.417695138993039
Revenue growth (%): -8.443430325079646
Rule of 40 score: -2.0257351860866075
Financial ratios for CCU — quarterly report dated 2024-09-30
Capital expenditures: 35848971.38093915
Operating cash flow: 51869963.878855236
Buffett classification: The Gruesome
Stock price: 11.07
Shares outstanding: 184751436
Market cap (USD): 2045198396.52
Free cash flow (dilution-adjusted): 16020992.497916088
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCU — annual report dated 2024-12-31
Total revenue: 2924011128.001208
Gross profit: 1322402654.6534455
Operating income: 225532450.7978054
Net income: 177726679.41813058
Capital expenditures: 101160250.66693512
Net tangible assets: 1126458177.8829215
Owner earnings: 76566428.75119546
Return on net tangible assets (%): 6.79709466844968
Capex to operating income (%): 44.85396682787233
Buffett classification: The Good
Stock price: 11.02
P/E ratio: 11.455572294410986
Shares outstanding: 184751436
Book value: 1683711994.7651887
P/B ratio: 1.2092096694980996
Market cap (USD): 2035960824.72
Debt to equity: 0.8457775355132623
Current ratio: 2.0595977300447657
Quick ratio: 1.5045529688622215
Effective tax rate (%): -6.654438731828241
Interest coverage ratio: 2.305686399621066
COGS to revenue (%): 54.774363134609146
SG&A to revenue (%): 25.867379552129194
Free cash flow (dilution-adjusted): 128283629.13373937
Buyback yield (%): 0
Retained earnings: 972243681.4818543
Inventory turnover: 3.3329519931437326
Receivables turnover: 5.35171692112984
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.158254414536749
FCF margin (%): 4.387248321501134
Revenue growth (%): 0.8240372349262121
Rule of 40 score: 5.211285556427346
Financial ratios for CCU — quarterly report dated 2024-12-31
Operating income: 147102461.36809784
Capital expenditures: 37693945.73916545
Capex to operating income (%): 25.624279423063513
Buffett classification: The Good
Stock price: 11.02
Shares outstanding: 184751436
Market cap (USD): 2035960824.72
Interest coverage ratio: 5.0879790642616625
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CCU — quarterly report dated 2025-03-31
Total revenue: 892322272.3006744
Gross profit: 417073803.39175415
Operating income: 95638243.44675557
Net income: 67101693.69448021
Capital expenditures: 28085986.642512605
Operating cash flow: 142337996.81340986
Net tangible assets: 1234281588.7116137
Owner earnings: 39015707.051967606
Return on net tangible assets (%): 3.161005349896985
Capex to operating income (%): 29.366899297088032
Buffett classification: The Good
Stock price: 14.78
P/E ratio: 10.1734623738142
Shares outstanding: 184751436
Book value: 1829242892.376192
P/B ratio: 1.4927630635934346
Market cap (USD): 2730626224.08
Debt to equity: 0.8263644470200351
Current ratio: 2.157400019055418
Quick ratio: 1.5757679347512878
Effective tax rate (%): 5.696543554331876
Interest coverage ratio: 4.222890081205099
COGS to revenue (%): 53.25973402900581
SG&A to revenue (%): 24.597237838042773
Free cash flow (dilution-adjusted): 107673933.25621493
Buyback yield (%): 0
Retained earnings: 1085478165.3098195
Inventory turnover: 0.9395776903513239
Receivables turnover: 1.8349608104632769
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8113833904021193
FCF margin (%): 12.066709147424868
Rule of 40 score: 12.066709147424868
Financial ratios for CCU — quarterly report dated 2025-06-30
Total revenue: 630958546.404091
Gross profit: 257678163.42073768
Operating income: -18865194.211728863
Net income: -12199978.2395822
Capital expenditures: 0
Operating cash flow: -35100641.9323251
Net tangible assets: 1606784898.2700467
Owner earnings: -12199978.2395822
Return on net tangible assets (%): -0.759278871286217
Buffett classification: The Gruesome
Stock price: 12.74
P/E ratio: 42.871762296272905
Shares outstanding: 184751436
Book value: 1752107496.4639318
P/B ratio: 1.3433726523003053
Market cap (USD): 2353733294.64
Debt to equity: 0.7846962360015949
Current ratio: 2.1443589966041197
Quick ratio: 2.1443589966041197
COGS to revenue (%): 59.16101352959231
SG&A to revenue (%): 43.71527502353797
Free cash flow (dilution-adjusted): -35100641.9323251
Buyback yield (%): 0
Retained earnings: 1073542596.0178435
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6046800189853971
FCF margin (%): -5.5630662477539765
Revenue growth (%): -29.290283792055238
Rule of 40 score: -34.853350039809214